Drug pipeline
Explore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Protein tyrosine kinase 2 beta (PTK2B), commonly known as proline-rich tyrosine kinase 2 (Pyk2), is a cytoplasmic, non-receptor tyrosine kinase belonging to the focal adhesion kinase (FAK) family. Unlike FAK, Pyk2 is highly sensitive to intracellular calcium levels and is primarily activated in response to calcium influx, membrane depolarization, and protein kinase C activation. It plays a critical role in regulating the actin cytoskeleton, cell polarization, migration, adhesion, and synaptic plasticity. PTK2B is implicated in several pathological conditions, including various cancers (such as glioblastoma, multiple myeloma, and breast cancer) where it promotes tumor cell invasion, survival, and metastasis. Additionally, PTK2B is a well-known genetic risk locus for late-onset Alzheimer's disease, contributing to amyloid-beta toxicity and tau phosphorylation. Therapeutic targeting of PTK2B is primarily pursued using small-molecule dual FAK/Pyk2 inhibitors, such as defactinib and PF-562271, which are being evaluated in clinical trials for oncology and inflammatory diseases.
ATP-competitive inhibition of tyrosine kinase activity, blocking autophosphorylation and downstream signaling pathways
3 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Protein tyrosine kinase 2 beta (PTK2B).